The over‐expression of eNOS in EPCs that were delivered to patients with PAH could achieve notable hemodynamic improvements, implying a crucial role for eNOS in ECFCs during PVD therapy 56. The gene discussed is NOS3; the disease is pulmonary arterial hypertension.